Roku reported its second quarterly earnings report ever, since becoming a publicly traded company. Andre Swanston, CEO of Tru Optik, an audience measurement and data management platform for OTT, was with us to share why he thinks Roku is positioned for success.
Swanston said the OTT space is "so wild" in terms of the growth in penetration and time spent. On top of that, he said most of that growth is on ad supported platforms, not services like Netflix. This bodes well for Roku because they are the only pure-play OTT company on the street, Swanston said.
Roku debuted a licensing program for smart audio devices and expects the first to ship this fall. They're going up against Amazon, Google, and Apple. Swanston said Roku has no strategic advantage for a smart speaker and does not anticipate it being a significant revenue generator.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
